Join us at Next Generation Dx Summit 2016!
Biological Dynamics' CEO, Raj Krishnan will be sharing his perspectives on validating clinical utility of cancer diagnostic solutions in Clinical Utility and Cost Effectiveness of Predictive Cancer Biomarkers panel discussion at 3:35 PM on Friday, August 26.
Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
